CSPC Innovation Pharmaceutical Co., Ltd. CSPC Innovation Pharmaceutical Co., Ltd.

CSPC Innovation Pharmaceutical Co., Ltd.

300765

Rank in Stocks #2324
Operating from its base in Shijiazhuang, China, CSPC Innovation Pharmaceutical... Operating from its base in Shijiazhuang, China, CSPC Innovation Pharmaceutical Co., Ltd. specializes in the manufacturing and commercialization of caffeine, vitamin C, health supplements, and various beverage offerings. The company functions as a subsidiary of the larger entity, CSPC Pharmaceutical Group Limited.
Share Price
$6.59
Market Cap
$8.36B
Change (1 day)
-5.40%
Change (1 year)
14.66%
Country
CN
Trade CSPC Innovation Pharmaceutical Co., Ltd. (300765)

Category

Consumer Defensive
Operating Margin for CSPC Innovation Pharmaceutical Co., Ltd. (300765)
Operating Margin as of October 2026 TTM: 27.01%
According to CSPC Innovation Pharmaceutical Co., Ltd. latest financial reports and stock price the company's current Operating Margin (TTM) is 27.01%. At the end of 2024 the company had an Operating Margin of -11.02%.
Operating Margin history for CSPC Innovation Pharmaceutical Co., Ltd. from 2014 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 27.01% -192.69%
2025 -29.14% 164.43%
2024 -11.02% -206.99%
2023 10.30% -68.39%
2022 32.58% 23.64%
2021 26.35% -3.59%
2020 27.33% 3.17%
2019 26.49% 18.63%
2018 22.33% -4.33%
2017 23.34% -16.10%
2016 27.82% 52.02%
2015 18.30% -4.64%
2014 19.19% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
14.06% -99.48%
CH
11.72% -99.57%
FR
11.42% -99.58%
JP
5.67% -99.79%
BR
-12.76% -100.47%
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.